Sertoli cell testicular tumors

Area of Science:

• Urology
• Oncology
• Endocrinology

Background:

• Testicular Sertoli cell tumors are rare neoplasms.
• They are typically considered benign but can rarely present as malignant.
• These tumors can exhibit endocrine activity.

Observation:

• This study presents 5 new cases of testicular Sertoli cell tumors.
• These cases add to the 75 previously reported worldwide.
• The rarity of these tumors makes extensive case reporting crucial.

Findings:

• Testicular Sertoli cell tumors account for less than 1.5% of all testis tumors.
• Malignancy occurs in approximately 10% of cases.
• Endocrine activity is observed in about 30% of patients.

Implications:

• Highlights the importance of considering malignancy and endocrine activity in Sertoli cell tumors.
• Emphasizes the need for continued case reporting to understand this rare condition.
• Informs clinical management strategies, including orchiectomy and close follow-up.